Macro Group Pharmaceuticals (Macro Capital) S.A.E

CASE:MCRO Stock Report

Market Cap: ج.م1.3b

Macro Group Pharmaceuticals (Macro Capital)E Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Hisham Wasfy

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure4yrs

Recent management updates

Recent updates

CEO

Hisham Wasfy

4yrs

Tenure

Dr. Hisham Wasfy is Executive Managing Director and Director of Macro Group Pharmaceuticals (Macro Capital) S.A.E. since 2021. Dr. Wasfy has experience and brings extensive leadership experience to the Com...

Board Members

NamePositionTenureCompensationOwnership
Hisham Wasfy
Executive MD & Director4yrsno datano data
Sahar El Sallab
Non Executive Independent Director4yrsno datano data
Ahmed Badreldin
Non Executive Director4yrsno datano data
Tamer Saeed
Non Executive Director4yrsno datano data
Ahmed Nayeb
Non Executive Chairman4yrsno data0.000090%
EGP 1.2k
Ahmed Rady
Non-Executive Vice Chairman4yrsno datano data
Norbert Lurz
Non-Executive Director4yrsno datano data
Samia El Baroudy
Non Executive Independent Director4yrsno datano data
Conor McNaughton
Non-Executive Director4yrsno datano data

4.0yrs

Average Tenure

52yo

Average Age

Experienced Board: MCRO's board of directors are considered experienced (4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 04:44
End of Day Share Price 2025/01/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Macro Group Pharmaceuticals (Macro Capital) S.A.E is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ahmed MoatazEFG-Hermes Research